Global Roundtable Stock Price, News & Analysis (OTCMKTS:GRCU) $0.0001 0.00 (-50.00%) (As of 01:13 PM ET) Add Compare Share Share Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.0001▼$0.0016Volume150,146 shsAverage Volume21.59 million shsMarket Capitalization$609,342.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest About Global Roundtable Stock (OTCMKTS:GRCU)Global Roundtable Corporation operates in the health and wellness business. It also provides products and ancillary services in the mental wellness segment and optical-vision medical care. The company was formerly known as Green Cures & Botanical Distribution Inc. and changed its name to Global Roundtable Corporation in May 2023. Global Roundtable Corporation was incorporated in 1986 and is based in Denver, Colorado.Read More GRCU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GRCU Stock News HeadlinesNovember 29, 2023 | americanbankingnews.comGlobal Roundtable Co. (OTCMKTS:GRCU) Sees Significant Increase in Short InterestSeptember 23, 2023 | finance.yahoo.comGlobal Roundtable Corporation (GRCU)November 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comSeptember 9, 2023 | npr.orgThe RoundtableMay 25, 2023 | finance.yahoo.comGreen Cures & Botanical Distribution, Inc. Announces Name Change and Share ReductionsMay 4, 2023 | finance.yahoo.comGreen Cures & Botanical Distribution Inc Announces Significant Sales Numbers for Marvel VisionMay 1, 2023 | finance.yahoo.comGREEN CURES & BOTANICAL DISTRIBUTION INC announces the acquisition of MARVEL VISION CENTERApril 27, 2023 | finance.yahoo.comGreen Cures & Botanical Distribution, Inc. Announces Publication of Annual ReportNovember 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comMarch 16, 2023 | investopedia.comRequired Minimum Distribution (RMD): Definition and CalculationAugust 20, 2022 | finance.yahoo.comGreen Cures & Botanical Distribution Inc. (GRCU)June 16, 2022 | news.yahoo.comRelax at these 10 tranquil green spaces in the SoutheastJune 16, 2022 | yahoo.comSome Palm Beach County green markets still open... but where?October 20, 2021 | finance.yahoo.comGreen Cures & Botanical Distribution Achieves OTC Market Status of Pink CurrentAugust 1, 2021 | barrons.comGreen Cures & Botanical Distribution Inc.February 25, 2021 | finance.yahoo.comGreen Cures & Botanical Distribution Launches Sale of Hollywood Green Botanical Vodka and Announces New Gin BrandDecember 24, 2020 | markets.businessinsider.comNews for Green Cures & Botanical Distribution IncDecember 16, 2020 | bloomberg.comGreen Cures & Botanical Distribution IncDecember 16, 2020 | finance.yahoo.comGreen Cures & Botanical Distribution Provides Corporate Updates to Shareholders in CEO LetterDecember 7, 2020 | finance.yahoo.comGreen Cures & Botanical Distribution Signs Lease for New Retail and Manufacturing FacilityDecember 7, 2020 | finance.yahoo.comGreen Cures & Botanical Distribution Hires Cannabis Expert as Vice President of Product DevelopmentSee More Headlines Receive GRCU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Roundtable and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today11/29/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Transportation services Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GRCU CUSIPN/A CIKN/A Webgreencurescorp.com Phone(844) 420-4728Fax415-339-4609Employees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares6,093,420,000Free FloatN/AMarket Cap$609,342.00 OptionableNot Optionable Beta0.96 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Rich ThomasChief Executive OfficerMr. Michael LajtayPresident, Chief Operating Officer and Lead Product DeveloperMr. Benjamin CraikChief Technology OfficerMr. David MoceriChief Marketing OfficerMr. Joseph TragesserConsultant & AdvisorKey CompetitorsZIVO BioscienceNASDAQ:ZIVOChina SXT PharmaceuticalsNASDAQ:SXTCAditxtNASDAQ:ADTXAACOTCMKTS:AACH9 Meters BiopharmaNASDAQ:NMTRView All Competitors GRCU Stock Analysis - Frequently Asked Questions How have GRCU shares performed in 2023? Global Roundtable's stock was trading at $0.0007 at the beginning of the year. Since then, GRCU stock has decreased by 85.7% and is now trading at $0.0001. View the best growth stocks for 2023 here. Are investors shorting Global Roundtable? Global Roundtable saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 25,300 shares, an increase of 2,430.0% from the October 31st total of 1,000 shares. Based on an average daily trading volume, of 14,155,500 shares, the short-interest ratio is currently 0.0 days. View Global Roundtable's Short Interest. How do I buy shares of Global Roundtable? Shares of GRCU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:GRCU) was last updated on 11/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Roundtable Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.